163 related articles for article (PubMed ID: 28883265)
21. Prognostic impact of TP53 mutations in adult acute lymphoblastic leukemia treated with a pediatric-type regimen.
Ou J; Xu X; Deng S; Liang H; Cai Z; Li J; Huang Z; Tang B; Wang Z; Zhou Y; Liu X; Liu Q; Zhou H
Leuk Lymphoma; 2024 Feb; 65(2):219-227. PubMed ID: 37938093
[TBL] [Abstract][Full Text] [Related]
22. The treatment of adolescents and young adults with acute lymphoblastic leukemia.
Advani AS; Hanna R
Leuk Lymphoma; 2020 Jan; 61(1):18-26. PubMed ID: 31452423
[TBL] [Abstract][Full Text] [Related]
23. Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
Muffly L; Lichtensztajn D; Shiraz P; Abrahão R; McNeer J; Stock W; Keegan T; Gomez SL
Cancer; 2017 Jan; 123(1):122-130. PubMed ID: 27622953
[TBL] [Abstract][Full Text] [Related]
24. Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.
Siegel SE; Stock W; Johnson RH; Advani A; Muffly L; Douer D; Reed D; Lewis M; Freyer DR; Shah B; Luger S; Hayes-Lattin B; Jaboin JJ; Coccia PF; DeAngelo DJ; Seibel N; Bleyer A
JAMA Oncol; 2018 May; 4(5):725-734. PubMed ID: 29450465
[TBL] [Abstract][Full Text] [Related]
25. New developments in ALL in AYA.
Boissel N
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):190-196. PubMed ID: 36485092
[TBL] [Abstract][Full Text] [Related]
26. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
[TBL] [Abstract][Full Text] [Related]
27. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
Ribera JM; Oriol A; Morgades M; Montesinos P; Sarrà J; González-Campos J; Brunet S; Tormo M; Fernández-Abellán P; Guàrdia R; Bernal MT; Esteve J; Barba P; Moreno MJ; Bermúdez A; Cladera A; Escoda L; García-Boyero R; Del Potro E; Bergua J; Amigo ML; Grande C; Rabuñal MJ; Hernández-Rivas JM; Feliu E
J Clin Oncol; 2014 May; 32(15):1595-604. PubMed ID: 24752047
[TBL] [Abstract][Full Text] [Related]
28. The current treatment approach to adolescents and young adults with acute lymphoblastic leukemia (AYA-ALL): challenges and considerations.
Jain H; Rajendra A; Sengar M; Goli VB; Thorat J; Muthuluri H; Tongaonkar AH; Kota KK; Gupta H; Sharma N; Eipe T; Mehta H
Expert Rev Anticancer Ther; 2022 Aug; 22(8):845-860. PubMed ID: 35734814
[TBL] [Abstract][Full Text] [Related]
29. Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.
Herold T; Gökbuget N
Curr Oncol Rep; 2017 May; 19(5):31. PubMed ID: 28361222
[TBL] [Abstract][Full Text] [Related]
30. Diversity of T-cell receptor gene rearrangements in South Indian patients with common acute lymphoblastic leukemia.
Sudhakar N; Nancy NK; Rajalekshmy KR; Rajkumar T
Iran J Immunol; 2009 Sep; 6(3):141-6. PubMed ID: 19801787
[TBL] [Abstract][Full Text] [Related]
31. Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?
Boissel N; Baruchel A
Blood; 2018 Jul; 132(4):351-361. PubMed ID: 29895662
[TBL] [Abstract][Full Text] [Related]
32. Adolescents with acute lymphoblastic leukemia treated at pediatric versus adult hospitals.
Pole JD; Alibhai SM; Ethier MC; Teuffel O; Portwine C; Zelcer S; Johnston DL; Silva M; Alexander S; Brandwein JM; Sung L
Ann Oncol; 2013 Mar; 24(3):801-6. PubMed ID: 23108950
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
Ding Z; Han MZ; Chen SL; Ma QL; Wei JL; Pang AM; Zhang XY; Liang C; Yao JF; Cao YG; Feng SZ; Jiang EL
Chin Med J (Engl); 2015 Aug; 128(15):2065-71. PubMed ID: 26228220
[TBL] [Abstract][Full Text] [Related]
34. Therapy of Philadelphia chromosome-negative acute lymphoblastic leukemia in adults: new paradigms.
Litzow MR
Future Oncol; 2009 Sep; 5(7):1039-50. PubMed ID: 19792972
[TBL] [Abstract][Full Text] [Related]
35. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
36. Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia.
Šálek C; Folber F; Froňková E; Procházka B; Marinov I; Cetkovský P; Mayer J; Doubek M;
Eur J Haematol; 2016 Mar; 96(3):276-84. PubMed ID: 25997106
[TBL] [Abstract][Full Text] [Related]
37. Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults.
Patel AA; Thomas J; Rojek AE; Stock W
Curr Treat Options Oncol; 2020 May; 21(7):57. PubMed ID: 32468488
[TBL] [Abstract][Full Text] [Related]
38. Important factors improving outcome of young adults with acute lymphoblastic leukemia (ALL).
Bleyer A
Best Pract Res Clin Haematol; 2021 Dec; 34(4):101322. PubMed ID: 34865694
[TBL] [Abstract][Full Text] [Related]
39. Evolving paradigms in the therapy of Philadelphia-chromosome-negative acute lymphoblastic leukemia in adults.
Litzow MR
Hematology Am Soc Hematol Educ Program; 2009; ():362-70. PubMed ID: 20008222
[TBL] [Abstract][Full Text] [Related]
40. Progress in the treatment of adults with acute lymphoblastic leukemia.
Larson S; Stock W
Curr Opin Hematol; 2008 Jul; 15(4):400-7. PubMed ID: 18536580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
